A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer

NCT03939871 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hormone Receptor Positive Advanced Breast Cancer

Interventions

DRUG: fluvestrant + oral vinorelbine

Sponsor

Chinese Academy of Medical Sciences